| Literature DB >> 28829774 |
D C Anderson1, Stacey A Lapp2, John W Barnwell3, Mary R Galinski2,4.
Abstract
Plasmodium vivax is a complex protozoan parasite with over 6,500 genes and stage-specific differential expression. Much of the unique biology of this pathogen remains unknown, including how it modifies and restructures the host reticulocyte. Using a recently published P. vivax reference genome, we report the proteome from two biological replicates of infected Saimiri boliviensis host reticulocytes undergoing transition from the late trophozoite to early schizont stages. Using five database search engines, we identified a total of 2000 P. vivax and 3487 S. boliviensis proteins, making this the most comprehensive P. vivax proteome to date. PlasmoDB GO-term enrichment analysis of proteins identified at least twice by a search engine highlighted core metabolic processes and molecular functions such as glycolysis, translation and protein folding, cell components such as ribosomes, proteasomes and the Golgi apparatus, and a number of vesicle and trafficking related clusters. Database for Annotation, Visualization and Integrated Discovery (DAVID) v6.8 enriched functional annotation clusters of S. boliviensis proteins highlighted vesicle and trafficking-related clusters, elements of the cytoskeleton, oxidative processes and response to oxidative stress, macromolecular complexes such as the proteasome and ribosome, metabolism, translation, and cell death. Host and parasite proteins potentially involved in cell adhesion were also identified. Over 25% of the P. vivax proteins have no functional annotation; this group includes 45 VIR members of the large PIR family. A number of host and pathogen proteins contained highly oxidized or nitrated residues, extending prior trophozoite-enriched stage observations from S. boliviensis infections, and supporting the possibility of oxidative stress in relation to the disease. This proteome significantly expands the size and complexity of the known P. vivax and Saimiri host iRBC proteomes, and provides in-depth data that will be valuable for ongoing research on this parasite's biology and pathogenesis.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28829774 PMCID: PMC5567661 DOI: 10.1371/journal.pone.0182561
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Giemsa-stained P. vivax iRBC isolated from biological replicate 1.
Thin smears were prepared from Percoll-gradient enriched iRBC, and show early nucleated schizonts (iRBC 1, 4 and 5) and large late-stage trophozoites (iRBC 2 and 3).
Fig 2Functional categories of P. vivax and S. boliviensis trophozoite-schizont transition iRBC proteins.
Major categories for both organisms include metabolism, translation, transcription, proteolysis and trafficking. Over 25% of P. vivax proteins (hypothetical and PIR proteins) have no annotated function. Numerous cytoskeletal proteins, particularly actin-related, are identified for S. boliviensis. Details of individual proteins, each identified more than once by a database search engine in the two combined biological replicate proteomes, are in S5 Table. These pie charts are similar to those of trophozoite-stage iRBC proteins [44], however the P. vivax hypothetical protein fraction has decreased. New P. vivax categories include PIR/VIR proteins and Plasmodium exported proteins.
GO-term enrichment analysis of P. vivax proteins in proteomes 1 and 2.
| GO ID | GO Term, Proteome 1 | Fold enrichment | Benjamini FDR | GO ID | GO Term, Proteome 2 | Fold enrichment | Benjamini FDR |
|---|---|---|---|---|---|---|---|
| GO:0006096 | glycolytic process | 3.96 | 0.010 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER | 3.79 | 0.038 |
| GO:0006090 | pyruvate metabolic process | 3.6 | 0.013 | GO:0009064 | glutamine family amino acid metabolic process | 3.79 | 0.043 |
| GO:0006414 | translational elongation | 3.05 | 0.019 | GO:0006096 | glycolytic process | 3.03 | 0.035 |
| GO:0051169 | nuclear transport | 2.86 | 0.010 | GO:0006090 | pyruvate metabolic process | 2.76 | 0.040 |
| GO:0015991 | ATP hydrolysis coupled proton transport | 2.83 | 0.020 | GO:0006414 | translational elongation | 2.62 | 0.040 |
| GO:0009166 | nucleotide catabolic process | 2.64 | 0.017 | GO:0015991 | ATP hydrolysis coupled proton transport | 2.44 | 0.041 |
| GO:0006184 | GTP catabolic process | 2.55 | 0.019 | GO:0016052 | carbohydrate catabolic process | 2.44 | 0.041 |
| GO:0006457 | protein folding | 2.45 | 0.001 | GO:0006511 | ubiquitin-dependent protein catabolic process | 2.27 | 0.009 |
| GO:0045454 | cell redox homeostasis | 2.38 | 0.019 | GO:0006413 | translational initiation | 2.17 | 0.040 |
| GO:0006511 | ubiquitin-dependent protein catabolic process | 2.14 | 0.017 | ||||
| GO:0006413 | translational initiation | 2.17 | 0.040 | ||||
| GO:0070003 | threonine-type peptidase activity | 3.81 | 0.005 | GO:0070003 | threonine-type peptidase activity | 3.28 | 0.009 |
| GO:0002161 | aminoacyl-tRNA editing activity | 3.67 | 0.046 | GO:0051082 | unfolded protein binding | 2.22 | 0.017 |
| GO:0016209 | antioxidant activity | 3.42 | 0.040 | GO:0004812 | aminoacyl-tRNA ligase activity | 2.15 | 0.013 |
| GO:0051020 | GTPase binding | 3.3 | 0.043 | GO:0003743 | translation initiation factor activity | 2.11 | 0.024 |
| GO:0019829 | cation-transporting ATPase activity | 2.75 | 0.036 | ||||
| GO:0051082 | unfolded protein binding | 2.73 | 0.007 | ||||
| GO:0003743 | translation initiation factor activity | 2.28 | 0.036 | ||||
| GO:0005852 | eukaryotic translation initiation factor 3 complex | 4 | 0.009 | GO:0044433 | cytoplasmic vesicle | 3.79 | 0.006 |
| GO:0000785 | chromatin | 3.85 | 0.023 | GO:0005798 | Golgi-associated vesicle | 3.79 | 0.017 |
| GO:0005839 | proteasome core complex | 3.81 | 0.003 | GO:0030137 | COPI-coated vesicle | 3.79 | 0.024 |
| GO:0005773 | vacuole | 3.67 | 0.039 | GO:0000785 | chromatin | 3.32 | 0.027 |
| GO:0015935 | small ribosomal subunit | 3.3 | 0.023 | GO:0005839 | proteasome core complex | 3.28 | 0.008 |
| GO:0030135 | coated vesicle | 3.05 | 0.023 | GO:0033176 | proton-transporting V-type ATPase complex | 2.76 | 0.033 |
| GO:0005798 | Golgi-associated vesicle | 2.93 | 0.044 | GO:0005794 | Golgi apparatus | 2.59 | 0.022 |
| GO:0033176 | proton-transporting V-type ATPase complex | 2.8 | 0.039 | GO:0015935 | small ribosomal subunit | 2.53 | 0.043 |
| GO:0005794 | Golgi apparatus | 2.32 | 0.038 | GO:0031410 | cytoplasmic vesicle | 2.41 | 0.022 |
| GO:0031410 | cytoplasmic vesicle | 2.8 | 0.011 |
DAVID-derived S. boliviensis functional annotation clusters in proteomes 1 and 2.
| Enrichment Score | Proteome 1 | Benjamini top term | Enrichment Score | Proteome 2 | Benjamini top term |
|---|---|---|---|---|---|
| 154.35 | extracellular exosome | 9.10E-178 | 80.19 | extracellular exosome | 5.20E-92 |
| 52.94 | intracellular organelle | 1.50E-58 | 14.81 | membrane-bounded organelle | 1.80E-29 |
| 25.72 | organelle lumen | 6.80E-37 | |||
| 3.71 | cytoplasmic vesicle | 3.10E-06 | |||
| 3.01 | endocytic vesicle lumen | 2.50E-04 | |||
| 2.36 | nucleocytoplasmic transport | 1.40E-05 | |||
| 2.09 | exocytosis | 5.60E-04 | |||
| 2.08 | autophagy | 3.00E-02 | |||
| 2.04 | RNA export from nucleus | 5.60E-05 | |||
| 50.2 | non-membrane-bounded organelle/cytoskeleton | 5.40E-60 | 11.07 | non-membrane-bounded organelle/cytoskeleton | 2.60E-17 |
| 29.67 | adherens junction | 9.50E-53 | 17.49 | adherens junction | 1.10E-25 |
| 19.14 | cytoskeleton | 1.80E-27 | 7.91 | cortical cytoskeleton | 7.00E-10 |
| 11.06 | cortical cytoskeleton | 1.80E-13 | 6.14 | spectrin-associated cytoskeleton | 1.30E-07 |
| 7.32 | actin cytoskeleton | 2.80E-18 | 5.89 | contractile fiber | 5.30E-09 |
| 6.16 | Intermediate filament | 4.90E-13 | 3.89 | actin cytoskeleton | 6.20E-10 |
| 5.91 | microtubules | 4.40E-07 | 2.95 | microtubule cytoskeleton | 1.80E-05 |
| 5.58 | contractile fiber | 4.40E-10 | 2.08 | dynein complex | 2.20E-04 |
| 5.27 | actin filament bundle | 5.90E-06 | |||
| 4.43 | spectrin-associated cytoskeleton | 9.90E-07 | |||
| 2.83 | myosin complex | 4.10E-05 | |||
| 2.01 | actin-myosin filament sliding | 5.50E-06 | |||
| 7.67 | oxidation-reduction process | 5.30E-12 | 5.14 | oxidation-reduction process | 1.20E-06 |
| 5.85 | antioxidant activity | 2.70E-08 | 4.78 | response to oxidative stress | 3.00E-07 |
| 3.28 | cell redox homeostasis | 5.70E-05 | 3.77 | Oxidoreductase | 6.10E-04 |
| 2.99 | hydrogen peroxide metabolic process | 1.10E-06 | 2.94 | glutathione metabolic process | 5.90E-03 |
| 2.85 | Oxidation | 2.40E-07 | |||
| 2.83 | glutathione metabolic process | 1.10E-03 | |||
| 2.4 | response to oxidative stress | 3.00E-07 | |||
| 31.5 | symbiosis, encompassing mutualism through parasitism | 2.80E-34 | 9.7 | symbiosis, encompassing mutualism through parasitism | 4.20E-11 |
| 12.2 | Viral nucleoprotein | 3.00E-15 | 2.62 | inclusion body assembly | 3.00E-03 |
| 7.84 | Pathogenic Escherichia coli infection | 1.80E-11 | |||
| 2.16 | establishment of viral latency | 3.10E-02 | |||
| 3.22 | viral genome replication | 1.40E-04 | |||
| 3.25 | inclusion body assembly | 2.00E-03 | |||
| 4.81 | erythrocyte homeostasis | 9.10E-09 | 2.88 | tissue homeostasis | 1.60E-04 |
DAVID-derived S. boliviensis functional annotation clusters in proteomes 1 and 2.
| Enrichment Score | Proteome 1 | Benjamini top term | Enrichment Score | Proteome 2 | Benjamini top term |
|---|---|---|---|---|---|
| 14.5 | protein folding | 3.80E-15 | 5.32 | protein folding | 6.80E-16 |
| 3.58 | protein stabilization | 4.90E-06 | 2.71 | response to unfolded protein | 3.40E-06 |
| 3.26 | chaperonin-containing T-complex | 2.80E-06 | 2.62 | inclusion body assembly | 3.00E-03 |
| 3.25 | inclusion body assembly | 2.00E-03 | |||
| 2.31 | unfolded protein response | 1.50E-03 | |||
| 2.19 | protein folding in endoplasmic reticulum | 1.10E-04 | |||
| 2.14 | chaperone mediated protein folding | 4.10E-02 | |||
| 25.4 | cellular macromolecular complex assembly | 1.20E-32 | 11.1 | macromolecular complex assembly | 4.40E-13 |
| 25.1 | ribonucleoprotein complex | 1.10E-69 | 11.7 | Proteasome | 3.30E-26 |
| 13.2 | spliceosome | 6.60E-28 | 4.31 | proteasome regulatory particle | 5.50E-11 |
| 9.97 | nucleosome | 1.80E-15 | 3.66 | regulation of proteasomal catabolic process | 1.30E-09 |
| 6.5 | ribosome assembly | 7.80E-10 | 3.02 | Protease | 1.10E-03 |
| 4.48 | proteasome accessory complex | 1.10E-08 | 2.04 | chromatin | 2.00E-04 |
| 2.64 | protein localization to chromatin | 3.10E-04 | |||
| 2.3 | lysosome | 2.00E-03 | |||
| 9.00 | small molecule metabolic process | 5.90E-19 | |||
| 11.99 | ATP metabolic process | 1.40E-17 | 6.93 | phosphorus metabolic process | 2.20E-09 |
| 11.09 | energy derivation by oxidation of organic compounds | 3.30E-17 | 6.85 | cofactor metabolic process | 5.10E-12 |
| 9.42 | small molecule metabolic process | 2.20E-16 | 4.86 | Protein biosynthesis | 6.20E-10 |
| 5.27 | tricarboxylic acid cycle | 3.20E-06 | 3.6 | aldehyde/NADP metabolic process | 3.10E-07 |
| 4.54 | NADP metabolic process | 1.70E-06 | 2.6 | Porphyrin biosynthesis | 2.80E-02 |
| 2.62 | ribonucleotide metabolic process | 1.50E-10 | 2.47 | regulation of transmembrane transport | 1.40E-04 |
| 2.43 | hemoglobin complex | 2.40E-05 | 2.43 | Purine biosynthesis | 7.90E-04 |
| 2.29 | glycogen metabolism | 5.50E-03 | 2.41 | hemoglobin complex | 1.60E-04 |
| 2.25 | pyruvate metabolism | 8.40E-04 | 2.39 | cysteine metabolic process | 9.90E-04 |
| 2.21 | DNA metabolic process | 5.30E-03 | 2.19 | L-ascorbic acid metabolic process | 2.20E-03 |
| 46.96 | poly(A) RNA binding | 1.10E-69 | 7.89 | poly(A) RNA binding | 1.80E-10 |
| 9.08 | regulation of RNA stability | 1.30E-23 | 3.33 | translation elongation | 1.00E-04 |
| 5.48 | regulation of translation | 2.10E-08 | 2.56 | Aminoacyl-tRNA synthetase | 3.20E-03 |
| 2.99 | regulation of RNA splicing | 1.20E-05 | 2.22 | translational initiation | 1.10E-02 |
| 2.59 | translation elongation factor activity | 4.10E-03 | |||
| 2.09 | aminoacyl-tRNA ligase activity | 4.20E-07 | |||
| 4.19 | negative regulation of programmed cell death | 9.20E-06 | 3.44 | regulation of cell death | 1.50E-04 |
| 3.42 | mitochondrion | 2.90E-08 | 3.32 | regulation of neuron apoptotic process | 1.90E-03 |
| 3.42 | apoptotic mitochondrial changes | 2.40E-06 | 2.44 | apoptotic mitochondrial changes | 1.70E-03 |
| 3.31 | regulation of apoptotic signaling pathway | 3.40E-05 | |||
| 3.25 | regulation of neuron apoptotic process | 2.30E-03 |
Hemoglobin, actin, PHIST/ CVC-8195 protein oxidized/nitrated residues.
| Proteome: | Trophozoite 1 | 2 | Trophozoite-Schizont Transition 1 | 2 |
|---|---|---|---|---|
| Protein | # oxidized residues | |||
| 17 | 20 | 36 | 24 | |
| 18 | 14 | 37 | 28 | |
| 20 | 0 | 10 | 6 | |
| 6 | 0 | 8 | 6 |
1 oxidized and nitrated residues include met, cys, his, trp, tyr and phe (see methods section)
but exclude met sulfoxide as met can be oxidized in solutions exposed to air.
2 peptide PEP ≤ 0.01
Trophozoite-schizont transition proteome oxidative modifications.
| Proteome 1 | Proteome 2 | Control | ||||
|---|---|---|---|---|---|---|
| peptides: | 5028 | 4377 | 3043 | |||
| # | # | # | ||||
| 1255 | 1449 | 604 | ||||
| unmodified | 133 | 0.1060 | 899 | 0.6204 | 48 | 0.0795 |
| O | 994 | 0.7920 | 491 | 0.3389 | 522 | 0.8642 |
| O2 | 128 | 0.1020 | 109 | 0.0752 | 34 | 0.0563 |
| 2162 | 2282 | 1137 | ||||
| unmodified | 1990 | 0.9204 | 2240 | 0.9816 | 1121 | 0.9859 |
| O | 81 | 0.0375 | 13 | 0.0057 | 14 | 0.0123 |
| O2 | 12 | 0.0056 | 7 | 0.0031 | 2 | 0.0018 |
| O3 | 13 | 0.0060 | 15 | 0.0066 | 0 | 0.0000 |
| NO2 | 60 | 0.0278 | 6 | 0.0026 | 0 | 0.0000 |
| NO2OH | 6 | 0.0028 | 1 | 0.0004 | 0 | 0.0000 |
| 180 | 295 | 401 | ||||
| unmodified | 122 | 0.6778 | 254 | 0.8610 | 233 | 0.5810 |
| O | 25 | 0.1389 | 25 | 0.0847 | 136 | 0.3392 |
| O2 | 17 | 0.0944 | 16 | 0.0542 | 26 | 0.0648 |
| O3 | 11 | 0.0611 | 0 | 0.0000 | 6 | 0.0150 |
| NO2 | 2 | 0.0111 | 0 | 0.0000 | 0 | 0.0000 |
| NO2OH | 7 | 0.0389 | 0 | 0.0000 | 0 | 0.0000 |
| 457 | 796 | 149 | ||||
| unmodified | 20 | 0.0438 | 1 | 0.0013 | 0 | 0.0000 |
| CAM | 403 | 0.8818 | 784 | 0.9849 | 149 | 1.0000 |
| O | 16 | 0.0350 | 0 | 0.0000 | 0 | 0.0000 |
| O2 | 8 | 0.0175 | 2 | 0.0025 | 0 | 0.0000 |
| O3 | 10 | 0.0219 | 9 | 0.0113 | 0 | 0.0000 |
| 2639 | 2659 | 1870 | ||||
| unmodified | 2513 | 0.9523 | 2611 | 0.9819 | 1846 | 0.9872 |
| O | 68 | 0.0258 | 30 | 0.0113 | 21 | 0.0112 |
| O2 | 32 | 0.0121 | 16 | 0.0060 | 3 | 0.0016 |
| NO2 | 13 | 0.0049 | 1 | 0.0004 | 0 | 0.0000 |
| NO2OH | 13 | 0.0049 | 1 | 0.0004 | 0 | 0.0000 |
| 1922 | 2600 | 1259 | ||||
| unmodified | 1813 | 0.9433 | 2539 | 0.9765 | 1246 | 0.9897 |
| O | 42 | 0.0219 | 26 | 0.0100 | 10 | 0.0079 |
| O2 | 41 | 0.0213 | 33 | 0.0127 | 3 | 0.0024 |
| NO2 | 16 | 0.0083 | 2 | 0.0008 | 0 | 0.0000 |
| NO2OH | 10 | 0.0052 | 0 | 0.0000 | 0 | 0.0000 |
1 All peptides have an observed precursor ion mass less than 5 ppm from the theoretical mass;
2 carboxamidomethyl
Fig 3Summary of P. vivax iRBC oxidative reactions [40, 119–122].
Hemoglobin (Hb) oxidation in food vacuoles may be central to generation of superoxide and production of hydrogen peroxide (H2O2), leading to production of hydroxyl radicals and observed protein sidechain oxidations. Food vacuoles may also be central to production of nitric oxide (NO) [123–124], which could be produced by additional pathways [125–128], leading to reaction with superoxide, generation of peroxynitrite (ONO2), and nitration and nitrohydroxylation of additional protein sidechains. This protein oxidation and nitration may lead to or be part of iRBC oxidative stress. FP IX (ferri- or ferroprotoporphyrin IX), iNOS, inducible nitric oxide synthase; SOD, superoxide dismutase; Cyt b5, Cytochrome b5.